ALHC HR chief sells shares for tax withholding

Alignment Healthcare, Inc. Chief Human Resources Officer Andreas P. Wagner reported open-market sales of Alignment Healthcare common stock primarily to cover tax withholding from vesting restricted stock units.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. Chief Human Resources Officer Andreas P. Wagner reported open-market sales of Alignment Healthcare common stock primarily to cover tax withholding from vesting restricted stock units. He sold 12,000 shares on March 18, 2026 at a weighted-average price of $17.84 per share and 11,602 shares on March 19, 2026 at a weighted-average price of $18.2207 per share.

The filing states these sales were required to satisfy tax obligations and "do not represent a discretionary trade" by Wagner, and were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025. After these transactions, he directly holds 148,628 shares of Alignment Healthcare common stock.

Insider Trade Summary 10b5-1

Net Seller: 23,602 shares

Net Sell 2 txns

Insider Wagner Andreas P.

Role Chief Human Resources Officer

Sold 23,602 shs ($425K)

Type	Security	Shares	Price	Value
Sale	Common Stock	11,602	$18.2207	$211K
Sale	Common Stock	12,000	$17.84	$214K

Holdings After Transaction: Common Stock — 148,628 shares (Direct)

Footnotes (4)

1. F1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
2. F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
3. F3. Date of Rule 10b5-1 plan adoption: 11/21/2025
4. F4. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.18 to $18.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Alignment Healthcare (ALHC) report for Andreas P. Wagner?

Alignment Healthcare’s Chief Human Resources Officer Andreas P. Wagner reported two open-market sales totaling 23,602 shares of common stock on March 18–19, 2026. These transactions were tied to restricted stock unit vesting and associated tax obligations.

At what prices did Andreas P. Wagner sell Alignment Healthcare (ALHC) shares?

Wagner sold 12,000 shares at a weighted-average price of $17.84 on March 18, 2026, and 11,602 shares at a weighted-average price of $18.2207 on March 19, 2026. Both involved multiple trades within stated price ranges.

Why were Alignment Healthcare (ALHC) shares sold by Andreas P. Wagner in this Form 4?

The filing explains the shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units. It explicitly states the transaction "does not represent a discretionary trade" by Wagner, indicating a mechanistic, tax-related sale.

Were Andreas P. Wagner’s ALHC stock sales made under a Rule 10b5-1 trading plan?

Yes. A footnote states the transactions were executed under a Rule 10b5-1 trading plan adopted on November 21, 2025. Such pre-arranged plans automate trades, reducing the significance of trade timing as a signal of insider sentiment.

How many Alignment Healthcare (ALHC) shares does Andreas P. Wagner hold after these sales?

After the reported transactions, Wagner directly holds 148,628 shares of Alignment Healthcare common stock. This figure, disclosed in the Form 4, shows his remaining equity position following the tax-related open-market sales in March 2026.

Do the reported ALHC insider sales indicate a change in Andreas P. Wagner’s investment outlook?

The Form 4 notes the shares were sold to satisfy tax withholding from restricted stock unit vesting and were executed under a Rule 10b5-1 plan. The filing characterizes them as non-discretionary, which limits their usefulness in interpreting his personal outlook.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 06:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wagner Andreas P.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S		12,000(1)	D	$17.84(2)	160,230	D
Common Stock	03/19/2026		S(3)		11,602	D	$18.2207(4)	148,628	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

3. Date of Rule 10b5-1 plan adoption: 11/21/2025

4. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.18 to $18.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Andreas P. Wagner	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)